Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the chemical formula C24H23N3O4 and a molecular weight of approximately 417.46 g/mol[2][1][7]. It belongs to the class of organic compounds known as benzanilides—aromatic compounds containing an anilide group in which the nitrogen atom is directly attached to a benzene ring[2]. The drug has been referenced as an experimental agent and does not have established clinical use or detailed pharmacological data available in public sources. Its mechanism of action, primary indication(s), developer(s), and manufacturer(s) are not specified in current databases. It is listed under several chemical registries and research resources but appears to be primarily used for research purposes rather than as an approved pharmaceutical product[2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-(4-methyl-benzoylamino)-biphenyl-3,4'-dicarboxylic acid 3-dimethylamide-4'-hydroxyamide.